Head-to-head comparison of 1-year aripiprazole long-acting injectable (LAI) versus paliperidone LAI in comorbid psychosis and substance use disorder: impact on clinical status, substance craving, and quality of life

Ilaria Cuomo, Georgios D Kotzalidis, Simone de Persis, Daria Piacentino, Filippo Perrini, Emanuela Amici, Sergio De Filippis
  • June 2018, Dove Medical Press
  • DOI: 10.2147/ndt.s171002
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Georgios D. Kotzalidis and emanuela amici